iodixanol has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaber, BL; Kolyada, AY; Liangos, O; Madias, NE | 1 |
| Atar, S; Eizenberg, S; Feldman-Idov, Y; Kristal, B; Marzuq, N; Ofir, P; Shema-Didi, L; Sussan, M | 1 |
1 trial(s) available for iodixanol and losartan potassium
| Article | Year |
|---|---|
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary Angiography; Cystatin C; Cytoprotection; Diabetic Nephropathies; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Humans; Infusions, Intravenous; Iohexol; Israel; Lipocalin-2; Male; Middle Aged; Prospective Studies; Protective Agents; Recombinant Proteins; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2016 |
1 other study(ies) available for iodixanol and losartan potassium
| Article | Year |
|---|---|
Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury.
Topics: Animals; Apoptosis; Caspases; Cell Survival; Contrast Media; Enzyme Activation; Epithelial Cells; Erythropoietin; In Situ Nick-End Labeling; Iohexol; Kidney Tubules; LLC-PK1 Cells; Recombinant Proteins; Reperfusion Injury; Swine; Triiodobenzoic Acids | 2008 |